Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Srikanth Vallurupalli

Concepts (296)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Coronary Artery Disease
12
2024
297
4.280
Why?
Atrial Fibrillation
5
2022
200
2.360
Why?
Percutaneous Coronary Intervention
9
2022
307
2.350
Why?
Ventricular Function, Right
6
2025
40
2.270
Why?
Ventricular Dysfunction, Right
3
2023
30
2.250
Why?
Echocardiography
13
2025
412
2.130
Why?
Aortic Valve Stenosis
5
2021
76
2.100
Why?
Myocardial Infarction
6
2025
413
2.000
Why?
Stents
8
2022
351
1.980
Why?
Angioplasty, Balloon, Coronary
4
2018
136
1.950
Why?
Echocardiography, Doppler
3
2025
54
1.540
Why?
Endocarditis
2
2022
31
1.310
Why?
Aortic Valve
3
2020
123
1.290
Why?
Thrombocytopenia
2
2022
89
1.270
Why?
Treatment Outcome
27
2025
5407
1.260
Why?
Electrocardiography
6
2024
267
1.210
Why?
Humans
71
2025
52336
1.200
Why?
Heart Failure
7
2025
571
1.200
Why?
Heart Ventricles
6
2025
268
1.140
Why?
Fractional Flow Reserve, Myocardial
4
2022
127
1.110
Why?
Ischemic Attack, Transient
2
2018
57
1.050
Why?
Anemia
2
2025
74
0.960
Why?
Veterans
2
2022
581
0.940
Why?
Pulmonary Artery
2
2025
146
0.930
Why?
Stroke
3
2021
509
0.920
Why?
Exercise Test
3
2024
141
0.850
Why?
Coronary Stenosis
2
2021
98
0.830
Why?
Risk Factors
17
2025
3872
0.830
Why?
Coronary Angiography
9
2022
366
0.810
Why?
Thrombosis
3
2024
253
0.780
Why?
Electric Countershock
1
2022
30
0.750
Why?
Endocarditis, Bacterial
1
2022
43
0.750
Why?
Atrial Appendage
1
2021
14
0.740
Why?
Kidney Diseases
3
2021
220
0.740
Why?
Retrospective Studies
16
2023
6578
0.720
Why?
Catheter Ablation
2
2021
125
0.720
Why?
Anticholesteremic Agents
1
2021
31
0.710
Why?
Hypercholesterolemia
1
2021
39
0.700
Why?
Cryosurgery
1
2021
36
0.690
Why?
Systole
4
2023
73
0.680
Why?
Male
34
2025
26696
0.670
Why?
Magnetic Resonance Imaging, Cine
3
2016
62
0.660
Why?
Operative Time
2
2017
77
0.660
Why?
Dyspnea
3
2018
78
0.650
Why?
Aged
22
2025
10109
0.650
Why?
Digitalis
1
2019
5
0.640
Why?
Heart
2
2021
357
0.640
Why?
Predictive Value of Tests
10
2022
943
0.640
Why?
Anticoagulants
3
2022
267
0.640
Why?
Middle Aged
24
2025
13014
0.610
Why?
Female
30
2025
28105
0.590
Why?
Cardiac Catheters
1
2018
11
0.580
Why?
Auscultation
1
2018
9
0.580
Why?
Heart Murmurs
1
2018
14
0.580
Why?
Asymptomatic Diseases
1
2018
38
0.580
Why?
Time Factors
9
2022
2957
0.560
Why?
Drug Prescriptions
1
2018
102
0.550
Why?
Coronary Disease
2
2015
152
0.550
Why?
Artifacts
1
2017
55
0.550
Why?
Heart Diseases
2
2017
222
0.540
Why?
Peripheral Arterial Disease
1
2018
75
0.540
Why?
Mediastinal Neoplasms
1
2017
18
0.530
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
145
0.530
Why?
Hospital Mortality
2
2018
428
0.520
Why?
Coronary Occlusion
1
2017
79
0.520
Why?
Surgical Procedures, Operative
1
2017
64
0.510
Why?
Absorbable Implants
1
2016
13
0.510
Why?
Tomography, Optical Coherence
1
2017
108
0.500
Why?
Acute Coronary Syndrome
1
2017
80
0.490
Why?
Pneumonia
1
2017
125
0.490
Why?
Respiratory Insufficiency
1
2017
114
0.490
Why?
Propafenone
1
2015
2
0.480
Why?
Tachycardia, Ectopic Atrial
1
2015
3
0.480
Why?
Flecainide
1
2015
4
0.480
Why?
Heart Conduction System
1
2015
24
0.480
Why?
Hypoparathyroidism
1
2015
5
0.470
Why?
Hypocalcemia
1
2015
13
0.470
Why?
Rhabdomyolysis
1
2015
12
0.470
Why?
Prognosis
6
2024
2094
0.470
Why?
Heart Rate
2
2021
319
0.460
Why?
Clinical Competence
1
2018
404
0.460
Why?
Thyroidectomy
1
2015
61
0.450
Why?
Cardiac Surgical Procedures
2
2017
320
0.450
Why?
Physician-Patient Relations
1
2015
144
0.430
Why?
Heart Neoplasms
1
2014
32
0.430
Why?
Fibroma
1
2014
40
0.430
Why?
Ventricular Function, Left
4
2019
172
0.420
Why?
Recurrence
4
2021
672
0.420
Why?
Theophylline
1
2013
17
0.420
Why?
Syncope
1
2013
30
0.410
Why?
Diabetes Mellitus, Type 2
4
2022
561
0.390
Why?
Physicians
1
2015
240
0.380
Why?
Heart Valve Prosthesis
2
2022
86
0.360
Why?
Heart Valve Prosthesis Implantation
2
2022
96
0.350
Why?
Stroke Volume
3
2025
153
0.350
Why?
Amyloidosis
3
2016
85
0.350
Why?
Octreotide
1
2010
9
0.330
Why?
Arkansas
6
2019
2028
0.330
Why?
Sulfonylurea Compounds
1
2010
6
0.330
Why?
Benzocaine
1
2009
4
0.320
Why?
Head and Neck Neoplasms
1
2013
288
0.320
Why?
Ventricular Remodeling
3
2021
65
0.320
Why?
Methemoglobinemia
1
2009
5
0.320
Why?
Hypoglycemia
1
2010
59
0.310
Why?
Echocardiography, Transesophageal
1
2009
60
0.310
Why?
Diagnosis, Differential
3
2018
1044
0.310
Why?
Anesthetics, Local
1
2009
79
0.300
Why?
Prospective Studies
3
2023
2428
0.290
Why?
Prosthesis Design
3
2022
255
0.290
Why?
Vasodilator Agents
2
2022
93
0.280
Why?
Reproducibility of Results
3
2025
1214
0.280
Why?
Myocardial Contraction
2
2019
112
0.280
Why?
Incidence
5
2019
1059
0.280
Why?
Coronary Vessels
2
2020
169
0.260
Why?
Chronic Disease
3
2018
583
0.260
Why?
Pressure
2
2017
103
0.250
Why?
Defibrillators, Implantable
2
2019
68
0.250
Why?
Ventricular Outflow Obstruction
1
2025
26
0.240
Why?
Randomized Controlled Trials as Topic
5
2022
594
0.230
Why?
Follow-Up Studies
5
2019
2268
0.230
Why?
Cardiomyopathies
2
2016
123
0.230
Why?
Foramen Ovale, Patent
2
2015
31
0.220
Why?
Cardiac Catheterization
3
2022
230
0.220
Why?
Myxoma
1
2024
18
0.220
Why?
Blood Transfusion
1
2025
128
0.220
Why?
Hepatitis C, Chronic
2
2015
86
0.220
Why?
Adult
9
2025
14139
0.200
Why?
Hospitalization
4
2022
732
0.200
Why?
Risk Assessment
4
2022
1323
0.200
Why?
Mitral Valve Insufficiency
1
2022
52
0.190
Why?
Bioprosthesis
1
2022
40
0.190
Why?
Electrodes
1
2022
35
0.190
Why?
Proportional Hazards Models
3
2020
443
0.190
Why?
Warfarin
1
2022
83
0.180
Why?
Pilot Projects
2
2022
719
0.180
Why?
Multiple Myeloma
4
2017
3049
0.180
Why?
Glycosides
1
2020
19
0.180
Why?
Sodium-Glucose Transporter 1
1
2020
6
0.180
Why?
Severity of Illness Index
2
2018
1021
0.180
Why?
Microscopy, Fluorescence, Multiphoton
1
2020
7
0.180
Why?
Vasodilation
1
2021
99
0.170
Why?
Tachycardia, Supraventricular
1
2021
37
0.170
Why?
Cardiovascular System
1
2020
55
0.170
Why?
United States
3
2022
5182
0.170
Why?
Calcinosis
1
2020
51
0.170
Why?
United States Department of Veterans Affairs
1
2022
293
0.170
Why?
Blood Pressure
1
2022
534
0.160
Why?
Digoxin
1
2019
29
0.160
Why?
Heart Failure, Systolic
1
2019
7
0.160
Why?
Electric Stimulation Therapy
1
2019
23
0.160
Why?
Inpatients
2
2018
205
0.160
Why?
Metoprolol
1
2019
13
0.150
Why?
Cardiotonic Agents
1
2019
84
0.150
Why?
Platelet Transfusion
1
2018
33
0.150
Why?
Kaplan-Meier Estimate
2
2017
484
0.150
Why?
Cerebrovascular Disorders
1
2018
48
0.150
Why?
Hepatitis C Antibodies
2
2015
19
0.140
Why?
Delivery of Health Care
1
2021
323
0.140
Why?
Databases, Factual
2
2018
706
0.140
Why?
Cardiovascular Diseases
3
2020
486
0.140
Why?
Renal Insufficiency, Chronic
1
2020
187
0.140
Why?
Cardiac Imaging Techniques
1
2017
9
0.140
Why?
Fever
1
2018
112
0.140
Why?
Logistic Models
2
2017
920
0.140
Why?
Hepacivirus
2
2015
106
0.140
Why?
Cell Transdifferentiation
1
2017
8
0.140
Why?
Xanthine Oxidase
1
2017
14
0.130
Why?
Foam Cells
1
2017
17
0.130
Why?
Hemorrhage
1
2018
209
0.130
Why?
Survival Rate
2
2019
940
0.130
Why?
Respiratory Sounds
1
2017
50
0.130
Why?
Cohort Studies
2
2018
1532
0.130
Why?
Myocytes, Smooth Muscle
1
2017
95
0.130
Why?
Radiographic Image Enhancement
1
2016
29
0.130
Why?
Gadolinium DTPA
1
2016
26
0.130
Why?
Chi-Square Distribution
1
2017
288
0.130
Why?
Propensity Score
1
2017
155
0.130
Why?
Inflammasomes
1
2017
66
0.130
Why?
Kidney
1
2020
708
0.120
Why?
Muscle, Smooth, Vascular
1
2017
137
0.120
Why?
Quality Improvement
1
2018
222
0.120
Why?
Magnetic Resonance Imaging
3
2024
1543
0.120
Why?
Voltage-Gated Sodium Channel Blockers
1
2015
5
0.120
Why?
Intermittent Claudication
1
2015
13
0.120
Why?
Ventricular Function
1
2015
19
0.120
Why?
Fundoplication
1
2015
20
0.120
Why?
Goiter
1
2015
4
0.120
Why?
Postpericardiotomy Syndrome
1
2015
4
0.120
Why?
Immobilization
1
2015
15
0.120
Why?
Supine Position
1
2015
28
0.120
Why?
Pericardiectomy
1
2015
6
0.120
Why?
Healthcare Disparities
1
2018
299
0.120
Why?
Colchicine
1
2015
24
0.120
Why?
Length of Stay
1
2018
659
0.120
Why?
Pericarditis
1
2015
20
0.120
Why?
Aged, 80 and over
3
2018
3391
0.120
Why?
Mucolipidoses
1
2014
4
0.120
Why?
Scavenger Receptors, Class E
1
2017
204
0.110
Why?
Secondary Prevention
1
2015
84
0.110
Why?
Carcinoma, Renal Cell
1
2015
111
0.110
Why?
Thoracotomy
1
2014
33
0.110
Why?
Sulfonamides
1
2015
133
0.110
Why?
Obesity, Morbid
1
2015
88
0.110
Why?
Septal Occluder Device
1
2014
36
0.110
Why?
Pyrimidines
1
2015
199
0.110
Why?
Kidney Neoplasms
1
2015
181
0.100
Why?
Bone Marrow Transplantation
1
2014
113
0.100
Why?
Laparoscopy
1
2015
180
0.100
Why?
Mitral Valve
2
2022
52
0.100
Why?
Prosthesis Failure
2
2022
111
0.090
Why?
Administration, Oral
1
2013
451
0.090
Why?
Tomography, X-Ray Computed
1
2017
1162
0.090
Why?
Postoperative Complications
2
2015
1066
0.090
Why?
Injections, Subcutaneous
1
2010
50
0.080
Why?
Pericardium
1
2010
29
0.080
Why?
Gastrointestinal Agents
1
2010
41
0.080
Why?
Drug Monitoring
1
2010
83
0.080
Why?
Quality of Life
1
2015
868
0.080
Why?
Cause of Death
2
2020
160
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1031
0.080
Why?
Lipid Metabolism
1
2010
188
0.080
Why?
Renal Dialysis
1
2010
179
0.070
Why?
Kidney Failure, Chronic
1
2010
210
0.070
Why?
Dose-Response Relationship, Drug
1
2010
1377
0.060
Why?
Exercise
1
2010
548
0.060
Why?
Blood Flow Velocity
1
2025
93
0.060
Why?
Oxidative Stress
1
2010
810
0.060
Why?
Disease Progression
2
2020
870
0.060
Why?
RNA, Viral
2
2015
125
0.060
Why?
Gadolinium
1
2024
44
0.050
Why?
Heart Atria
1
2024
63
0.050
Why?
Sensitivity and Specificity
1
2025
879
0.050
Why?
Contrast Media
1
2024
174
0.050
Why?
Vitamin K
1
2022
16
0.050
Why?
American Heart Association
1
2022
31
0.050
Why?
Telemetry
1
2021
29
0.040
Why?
Tachycardia
1
2021
28
0.040
Why?
Acute Disease
1
2022
374
0.040
Why?
Glucosides
1
2020
24
0.040
Why?
Platelet Aggregation Inhibitors
1
2022
181
0.040
Why?
Diabetic Ketoacidosis
1
2020
17
0.040
Why?
Glomerular Filtration Rate
1
2020
124
0.040
Why?
Early Diagnosis
1
2020
87
0.040
Why?
Benzhydryl Compounds
1
2020
69
0.040
Why?
Exercise Tolerance
1
2019
46
0.040
Why?
Death, Sudden, Cardiac
1
2019
59
0.040
Why?
Anti-Arrhythmia Agents
1
2019
81
0.040
Why?
Recovery of Function
1
2019
200
0.040
Why?
Oxygen Consumption
1
2019
198
0.040
Why?
Adrenergic beta-Antagonists
1
2019
110
0.040
Why?
Feasibility Studies
1
2020
402
0.040
Why?
Uric Acid
1
2017
25
0.030
Why?
Scavenger Receptors, Class A
1
2017
39
0.030
Why?
Referral and Consultation
1
2018
292
0.030
Why?
Registries
1
2020
580
0.030
Why?
RNA Interference
1
2017
186
0.030
Why?
Transfection
1
2017
372
0.030
Why?
Biopsy, Needle
1
2016
182
0.030
Why?
Hernia, Hiatal
1
2015
9
0.030
Why?
ROC Curve
1
2016
251
0.030
Why?
Disease Models, Animal
1
2020
1484
0.030
Why?
Mice, Inbred C57BL
1
2020
1903
0.030
Why?
Patient Acceptance of Health Care
1
2018
355
0.030
Why?
Gastroesophageal Reflux
1
2015
48
0.030
Why?
Tubulin Modulators
1
2015
28
0.030
Why?
Indazoles
1
2015
47
0.030
Why?
Seroepidemiologic Studies
1
2014
44
0.030
Why?
Multivariate Analysis
1
2016
590
0.030
Why?
Reactive Oxygen Species
1
2017
425
0.030
Why?
Biopsy
1
2016
604
0.030
Why?
Survival Analysis
1
2016
671
0.030
Why?
Pneumonectomy
1
2014
29
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Prosthesis Implantation
1
2014
49
0.030
Why?
Posture
1
2014
66
0.030
Why?
Anti-Inflammatory Agents
1
2015
166
0.030
Why?
Myocardium
1
2016
480
0.030
Why?
Age Distribution
1
2013
174
0.030
Why?
Polymerase Chain Reaction
1
2014
460
0.030
Why?
Syndrome
1
2014
247
0.030
Why?
Immunohistochemistry
1
2016
985
0.030
Why?
Cell Line, Tumor
1
2017
1436
0.020
Why?
Ventricular Dysfunction, Left
1
2014
106
0.020
Why?
Transplantation, Autologous
1
2014
488
0.020
Why?
Comorbidity
1
2013
624
0.020
Why?
Oxygen
1
2014
336
0.020
Why?
alpha-2-HS-Glycoprotein
1
2010
2
0.020
Why?
Thiobarbituric Acid Reactive Substances
1
2010
11
0.020
Why?
Signal Transduction
1
2017
1716
0.020
Why?
Blood Proteins
1
2010
84
0.020
Why?
C-Reactive Protein
1
2010
155
0.020
Why?
Interleukin-6
1
2010
278
0.020
Why?
Lung Neoplasms
1
2014
636
0.020
Why?
Animals
1
2020
13523
0.020
Why?
Young Adult
1
2013
4319
0.010
Why?
Adolescent
1
2013
6692
0.010
Why?
Vallurupalli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description